TME Pharma Signs Binding Exclusive Negotiation Agreement with Japanese TMS Co., Ltd.
Valid market news retained in the public archive without immediate LiveCast distribution.
Related stories
AstraZeneca Q3 Adjusted Earnings and Revenue Rise, Outlook Reaffirmed
M impact | EQUITY | Oct 30, 2026, 10:07 AM UTC
BrightSpring Health Reports Third-Quarter Results, Raises 2026 Guidance
M impact | EQUITY | Oct 30, 2026, 10:02 AM UTC
Reddit Reports Q3 2026 Revenue of $894.96M, Net Income of $283.26M
Reddit reported revenue up 53% year over year to $894.96 million, net income up 74.1% to $283.26 million and diluted EPS up 75% to $1.40. Advertising revenue growth and stronger ad
M impact | EQUITY | Oct 30, 2026, 10:01 AM UTC
US Midterms, Earnings and Jobs Report Set to Test AI-Wary Market
US midterm elections, a heavy slate of corporate earnings and the monthly jobs report will test stock investors next week after setbacks in the AI trade.
M impact | EQUITY | Oct 30, 2026, 10:00 AM UTC
European session market picture: S&P 500 -1.02%, Nasdaq 100 -2.29%; EUR/USD +0.19%, WTI +2.02%, LLOY leads volume
European session market picture. US index futures: S and P futures is down 1.02 percent, Nasdaq futures is down 2.29 percent, Dow futures is up 0.02 percent and Russell futures is
M impact | EQUITY | Oct 30, 2026, 10:00 AM UTC
Intel outlook raises new doubts about earnings recovery
A Street View report says Intel's outlook has raised new questions about its earnings recovery, citing weakness in the PC market, manufacturing problems and expansion costs.
M impact | EQUITY | Oct 30, 2026, 09:58 AM UTC